{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:14Z","timestamp":1790937134317,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The inhibition of <jats:italic>Plasmodium<\/jats:italic> cytosolic phenylalanine tRNA-synthetase (cFRS) by a novel series of bicyclic azetidines has shown the potential to prevent malaria transmission, provide prophylaxis, and offer single-dose cure in animal models of malaria. To date, however, the molecular basis of <jats:italic>Plasmodium<\/jats:italic> cFRS inhibition by bicyclic azetidines has remained unknown. Here, we present structural and biochemical evidence that bicyclic azetidines are competitive inhibitors of L-Phe, one of three substrates required for the cFRS-catalyzed aminoacylation reaction that underpins protein synthesis in the parasite. Critically, our co-crystal structure of a\u00a0<jats:italic>Pvc<\/jats:italic>FRS-BRD1389 complex shows that the bicyclic azetidine ligand binds to two distinct sub-sites within the <jats:italic>Pv<\/jats:italic>cFRS catalytic site. The\u00a0ligand occupies the L-Phe site along with an auxiliary cavity and traverses past the ATP binding site. Given that BRD1389 recognition residues are conserved amongst apicomplexan FRSs, this work lays a structural framework for the development of drugs against both <jats:italic>Plasmodium<\/jats:italic> and related apicomplexans.<\/jats:p>","DOI":"10.1038\/s41467-020-20478-5","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:36:08Z","timestamp":1610476568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines"],"prefix":"10.1038","volume":"12","author":[{"given":"Manmohan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manickam","family":"Yogavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-4354","authenticated-orcid":false,"given":"Karl","family":"Harlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-5287","authenticated-orcid":false,"given":"Bruno","family":"Melillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Gonse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-6506","authenticated-orcid":false,"given":"Suhel","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Mitasev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis G.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-7558","authenticated-orcid":false,"given":"Stuart L.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"20478_CR1","unstructured":"World Health Organization (2019) World Malaria Report 2019 (WHO, Geneva)."},{"key":"20478_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature19804","volume":"538","author":"N Kato","year":"2016","unstructured":"Kato, N. et al. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature 538, 344\u2013349 (2016).","journal-title":"Nature"},{"key":"20478_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.drudis.2018.01.050","volume":"23","author":"Y Manickam","year":"2018","unstructured":"Manickam, Y. et al. Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum. Drug Discov. Today 23, 1233\u20131240 (2018).","journal-title":"Drug Discov. Today"},{"key":"20478_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/BJ20140998","volume":"465","author":"A Sharma","year":"2015","unstructured":"Sharma, A. & Sharma, A. Plasmodium falciparum mitochondria import tRNAs along with an active phenylalanyl-tRNA synthetase. Biochem. J. 465, 459\u2013469 (2015).","journal-title":"Biochem. J."},{"key":"20478_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.str.2010.01.002","volume":"18","author":"I Finarov","year":"2010","unstructured":"Finarov, I., Moor, N., Kessler, N., Klipcan, L. & Safro, M. G. Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patterns. Structure 18, 343\u2013353 (2010).","journal-title":"Structure"},{"key":"20478_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/1087057112465980","volume":"18","author":"I Cestari","year":"2013","unstructured":"Cestari, I. & Stuart, K. A spectrophotometric assay for quantitative measurement of aminoacyl-tRNA synthetase activity. J. Biomol. Screen. 18, 490\u2013497 (2013).","journal-title":"J. Biomol. Screen."},{"key":"20478_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10969-014-9182-1","volume":"15","author":"S Khan","year":"2014","unstructured":"Khan, S., Sharma, A., Belrhali, H., Yogavel, M. & Sharma, A. Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin. J. Struct. Funct. Genomics 15, 63\u201371 (2014).","journal-title":"J. Struct. Funct. Genomics"},{"key":"20478_CR8","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1021\/acs.jmedchem.8b00565","volume":"61","author":"P Das","year":"2018","unstructured":"Das, P. et al. Specific stereoisomeric conformations determine the drug potency of cladosporin scaffold against malarial parasite. J. Med. Chem. 61, 5664\u20135678 (2018).","journal-title":"J. Med. Chem."},{"key":"20478_CR9","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1073\/pnas.1814685116","volume":"116","author":"B Baraga\u00f1a","year":"2019","unstructured":"Baraga\u00f1a, B. et al. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Proc. Natl Acad. Sci. USA 116, 7015\u20137020 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"20478_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature11774","volume":"494","author":"H Zhou","year":"2013","unstructured":"Zhou, H., Sun, L., Yang, X. L. & Schimmel, P. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase. Nature 494, 121\u2013124 (2013).","journal-title":"Nature"},{"key":"20478_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.str.2015.02.011","volume":"23","author":"V Jain","year":"2015","unstructured":"Jain, V. et al. Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis. Structure 23, 819\u2013829 (2015).","journal-title":"Structure"},{"key":"20478_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.str.2017.07.015","volume":"25","author":"V Jain","year":"2017","unstructured":"Jain, V. et al. Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis. Structure 25, 1495\u20131505.e6 (2017).","journal-title":"Structure"},{"key":"20478_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/anie.200703073","volume":"47","author":"TE Nielsen","year":"2008","unstructured":"Nielsen, T. E. & Schreiber, S. L. Towards the optimal screening collection: a synthesis strategy. Angew. Chem. Int. Ed. 47, 48\u201356 (2008).","journal-title":"Angew. Chem. Int. Ed."},{"key":"20478_CR14","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1021\/jo300974j","volume":"77","author":"JT Lowe","year":"2012","unstructured":"Lowe, J. T. et al. Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries. J. Org. Chem. 77, 7187\u20137211 (2012).","journal-title":"J. Org. Chem."},{"key":"20478_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrd.2018.53","volume":"17","author":"CJ Gerry","year":"2018","unstructured":"Gerry, C. J. & Schreiber, S. L. Chemical probes and drug leads from advances in synthetic planning and methodology. Nat. Rev. Drug Discov. 17, 333\u2013352 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"20478_CR16","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov, A. D. et al. A high-performance quantum chemistry software program with strengths in life and materials sciences. Int. J. Quantum Chem. 113, 2110\u20132142 (2013).","journal-title":"Int. J. Quantum Chem."},{"key":"20478_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673\u2013677 (1976).","journal-title":"Science"},{"key":"20478_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins, R. E., Canfield, C. J., Haynes, D. E. & Chulay, J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16, 710\u2013718 (1979).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20478_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","volume":"48","author":"MT Makler","year":"1993","unstructured":"Makler, M. T. et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Med. Hyg. 48, 739\u2013741 (1993).","journal-title":"Am. J. Med. Hyg."},{"key":"20478_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1107\/S0907444913015308","volume":"69","author":"G Winter","year":"2013","unstructured":"Winter, G., Lobley, C. M. C. & Prince, S. M. Decision making in xia2. Acta Crystallogr. Sect. D Biol. Crystallogr. 69, 1260\u20131273 (2013).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"20478_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1107\/S2059798317017235","volume":"74","author":"G Winter","year":"2018","unstructured":"Winter, G. et al. DIALS: Implementation and evaluation of a new integration package. Acta Crystallogr. Sect. D Struct. Biol. 74, 85\u201397 (2018).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"20478_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"20478_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1107\/S0907444909012098","volume":"65","author":"TC Terwilliger","year":"2009","unstructured":"Terwilliger, T. C. et al. Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr. D Biol. Crystallogr. 65, 582\u2013601 (2009).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"20478_CR24","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"20478_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"20478_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"20478_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"20478_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequenc alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"20478_CR29","first-page":"87","volume":"72","author":"EF Pettersen","year":"2015","unstructured":"Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. Acta Crystallogr. Sect. D Biol. Crystallogr. 72, 87\u201388 (2015).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"20478_CR30","unstructured":"PyMOL: http:\/\/www.pymol.org"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20478-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:07:40Z","timestamp":1669975660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20478-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["20478"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20478-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L.S. is a shareholder and serves on the Board of Directors of Jnana Therapeutics; is a shareholder of Forma Therapeutics and Decibel Therapeutics; is a shareholder and advises Kojin Therapeutics, Kisbee Therapeutics and Eikonizo Therapeutics; serves on the Scientific Advisory Boards of Eisai Co., Ltd., Ono Pharma Foundation, Exo Therapeutics, Biogen, Inc. and F-Prime Capital Partners; and the Board of Advisers of the Genomics Institute of the Novartis Research Foundation; and is a Novartis Faculty Scholar. The Broad Institute and Harvard have filed patent applications relating to work described in this manuscript, including \u201cCompounds and Methods for Treating Parasitic Diseases\u201d (PCT\/US18\/23270, filed on March 20, 2018 and published as WO18\/175385), and \u201cApicomplexan Parasite Inhibition\u201d (unpublished).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}